CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 23 | 1 | 21 | −1 |
| Shares | 1.23M | 100 | 1.30M | +69.8K (+5.7%) |
| Value | $343.5K | $0 | $232.0K | −$111.5K (−32.5%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 90,487 | $16.0K | 0.00% |
| Renaissance Technologies LLC | 56,800 | $10.0K | 0.00% |
| Goldman Sachs Group Inc | 18,549 | $3.00K | 0.00% |
| Bank of America Corp | 177 | $0 | 0.00% |
Sold out (5)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 20,721 | $6.00K |
| United Capital Financial Advisers, LLC | 18,944 | $5.00K |
| StoneX Group Inc. | 15,921 | $4.46K |
| Citigroup Inc | 13,400 | $4.00K |
| Millennium Management LLC | 10,384 | $3.00K |
Not filed for Q3 2022 yet (1)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 100 | $0 |